These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37752265)

  • 1. Formulation development, in vivo bioequivalence and pediatric PBPK modeling studies of taste-masked ciprofloxacin chewable tablets.
    Usmani MT; Shoaib MH; Siddiqui F; Ahmed FR; Yousuf RI; Saleem MT
    Sci Rep; 2023 Sep; 13(1):16070. PubMed ID: 37752265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of Child-Friendly Lisdexamfetamine Chewable Tablets Using Ion Exchange Resin as a Taste-Masking Carrier Based on the Concept of Quality by Design (QbD).
    Zhu C; Chen J; Shi L; Liu Q; Liu C; Zhang F; Wu H
    AAPS PharmSciTech; 2023 Jun; 24(5):132. PubMed ID: 37291437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Taste Masked Orodispersible Formulation of Fexofenadine Hydrochloride Using Ion Exchange Resins.
    Suares D; Hiray A
    Indian J Pharm Sci; 2015; 77(5):550-5. PubMed ID: 26798169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation and development of taste masked fast-disintegrating tablets (FDTs) of Chlorpheniramine maleate using ion-exchange resins.
    Yewale CP; Rathi MN; Kore GG; Jadhav GV; Wagh MP
    Pharm Dev Technol; 2013; 18(2):367-76. PubMed ID: 22023351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation and evaluation of sublingual tablets containing Sumatriptan succinate.
    Prajapati ST; Patel PB; Patel CN
    Int J Pharm Investig; 2012 Jul; 2(3):162-8. PubMed ID: 23373008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of Oral Flexible Tablet (OFT) Formulation for Pediatric and Geriatric Patients: a Novel Age-Appropriate Formulation Platform.
    Chandrasekaran P; Kandasamy R
    AAPS PharmSciTech; 2017 Aug; 18(6):1972-1986. PubMed ID: 27921260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel and discriminative method of in vitro disintegration time for preparation and optimization of taste-masked orally disintegrating tablets of carbinoxamine maleate.
    Liu Y; Li P; Qian R; Sun T; Fang F; Wang Z; Ke X; Xu B
    Drug Dev Ind Pharm; 2018 Aug; 44(8):1317-1327. PubMed ID: 29521132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation and evaluation of taste-masked levocetirizine dihydrochloride orally disintegrating tablets.
    Devireddy SR; Gonugunta CS; Veerareddy PR
    PDA J Pharm Sci Technol; 2009; 63(6):521-6. PubMed ID: 20169858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and evaluation of orally disintegrating tablets of taste masked phencynonate HCl using ion-exchange resin.
    Ge Z; Yang M; Wang Y; Shan L; Gao C
    Drug Dev Ind Pharm; 2015 Jun; 41(6):934-41. PubMed ID: 24785576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation and characterization of patient-friendly dosage form of ondansetron hydrochloride.
    Bhoyar P; Biyani D; Umekar M
    J Young Pharm; 2010 Jul; 2(3):240-6. PubMed ID: 21042478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fast Disintegrating Combination Tablet of Taste Masked Levocetrizine Dihydrochloride and Montelukast Sodium: Formulation Design, Development, and Characterization.
    Gupta MM; Gupta N; Chauhan BS; Pandey S
    J Pharm (Cairo); 2014; 2014():568320. PubMed ID: 26556198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and Bioequivalence Evaluation of Two Montelukast Sodium Chewable Tablets in Healthy Chinese Volunteers Under Fasted and Fed Conditions.
    Li W; Wang Y; Pei Y; Xia Y
    Drug Des Devel Ther; 2021; 15():1091-1099. PubMed ID: 33727797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of medicated chewing gum of taste masked levocetirizine dihydrochloride using different gum bases:
    Marzouk MA; Darwish MK; Abd El-Fattah MA
    Drug Dev Ind Pharm; 2020 Mar; 46(3):395-402. PubMed ID: 31996053
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacokinetics and bioequivalence study of two ciprofloxacin hydrochloride tablets in healthy Chinese subjects under fasting and fed conditions: A randomized, open-label, two-formulation, two-sequence, two-period, single-dose crossover study.
    Qin F; Wang GM; Huang JY; Wu JR; Song WJ; Deng J; Xiao Y; Wang JS; Zhu KW
    Int J Clin Pharmacol Ther; 2021 Dec; 59(12):804-816. PubMed ID: 34503644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation and In vitro Evaluation of Sustained Release Dosage Form with Taste Masking of Metformin Hydrochloride.
    Bhoyar PK; Biyani DM
    Indian J Pharm Sci; 2010 Mar; 72(2):184-90. PubMed ID: 20838521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and evaluation of orally disintegrating tablets containing taste-masked microcapsules of berberine hydrochloride.
    Hu X; Li Y; Zhang E; Wang X; Xing M; Wang Q; Lei J; Huang H
    AAPS PharmSciTech; 2013 Mar; 14(1):29-37. PubMed ID: 23180226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo correlation of disintegration and bitter taste masking using orally disintegrating tablet containing ion exchange resin-drug complex.
    Kim JI; Cho SM; Cui JH; Cao QR; Oh E; Lee BJ
    Int J Pharm; 2013 Oct; 455(1-2):31-9. PubMed ID: 23933050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioequivalence study of two limaprost alfadex 5 microg tablets in healthy subjects: moisture-resistant tablet (dextran formulation) versus standard tablet (lactose formulation).
    Nakade S; Komaba J; Ohno T; Kitagawa J; Furukawa K; Miyata Y
    Int J Clin Pharmacol Ther; 2008 Jan; 46(1):42-7. PubMed ID: 18218297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Taste masking of ondansetron hydrochloride by polymer carrier system and formulation of rapid-disintegrating tablets.
    Khan S; Kataria P; Nakhat P; Yeole P
    AAPS PharmSciTech; 2007 Jun; 8(2):Article 46. PubMed ID: 17622121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a taste-masked oral suspension of clindamycin HCl using ion exchange resin Amberlite IRP 69 for use in pediatrics.
    Alayoubi A; Daihom B; Adhikari H; Mishra S; Helms R; Almoazen H
    Drug Dev Ind Pharm; 2016 Oct; 42(10):1579-89. PubMed ID: 26926148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.